• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
NextPrevious

Accepting the baton from Ferg and lacing up my running shoes!

By Bladder Cancer Canada | Latest news and stories | 8 March, 2022 | 1

As a longstanding volunteer with BCC, I thought I was well versed in “all things BCC”. These past few months, learning the ropes as the incoming Chair have proven me wrong – and in a very good way! 

I’ve learned that BCC is a highly engaged and committed community that continues to exceed expectations. As we’ve seen through COVID, BCC was not only able to survive but thrive in the midst of uncertainty – supporting patients and families in new ways, deepening our resolve to respond to patients when they needed us most, and continuing to raise awareness, and funds to support our mission on all fronts.

As Chair, I feel privileged to work alongside amazing volunteers, staff and medical leaders who are equally devoted to our vision and mission. The future looks bright yet there is much more to do. 

Our Board has had initial discussions regarding the strategic path forward as we see a glimmer of hope for a new normal in the face of COVID. The focus over the next few years will be to ensure our continued relevance to patients and families, making sure that we are meeting their evolving needs for support and information. We also want to grow our outreach capabilities to help more people as they journey through bladder cancer. Part of this effort means strengthening our ability to support francophone patients and families living in Quebec and across Canada. We also hope to resume our in-person events such that we can bring back a sense of connection and community. Additionally, we are committed more than ever to increasing the awareness about bladder cancer in the general public and amongst healthcare practitioners. Early diagnosis is key! Our ongoing support to the medical research community is also leading to advanced and new treatment options to improve the quality of life and outcomes for bladder cancer patients.

In the coming months, Michelle Colero, our highly energized Executive Director, along with staff and volunteers will lead us into Bladder Cancer Awareness Month (in May) and preparations for our annual awareness and fundraising walk – Canada Walks for Bladder Cancer (in September). Exciting times are ahead, and we invite you to join us! Contact us today at info@bladdercancercanada.org to share your interest in making a difference.

Best to you always, 

Michele Zielinski
Survivor and Chair
Bladder Cancer Canada

No tags.

Related Post

  • Volunteer’s personal approach leads to deeper commitment from corporate supporter

    By Bladder Cancer Canada | 0 comment

    By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

  • “The risk of recurrence of my cancer is high, so I need to take care of myself.”

    By Bladder Cancer Canada | 0 comment

    Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

  • This May, we’re making bladder cancer impossible to ignore! 

    By Bladder Cancer Canada | Comments are Closed

    Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

  • Bladder cancer & COVID-19 FAQ

    By Bladder Cancer Canada | Comments are Closed

    Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

  • Protecting Yourself During the Coronavirus Outbreak

    By Bladder Cancer Canada | Comments are Closed

    (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

  • Health Canada Approves BALVERSA

    By Bladder Cancer Canada | Comments are Closed

    In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 

    By Bladder Cancer Canada | Comments are Closed

    We have developed this easy-to-understand resource aimed at increasing awareness of hematuria.

  • Our First Annual Research Report Is Live! 

    By Bladder Cancer Canada | Comments are Closed

    Our first Annual Research Report brings you exciting updates from the world of bladder cancer research.

  • Tax Season is Upon Us! 

    By Bladder Cancer Canada | Comments are Closed

    Spring has sprung and so has tax season! Don’t miss out on valuable credits or deductions! 

  • Happy National Volunteer Week 2025!

    By Bladder Cancer Canada | Comments are Closed

    National Volunteer Week is celebrated annually to honour all the volunteers who make a powerful impact.

  • Patient Story: Stéphanie

    By Bladder Cancer Canada | Comments are Closed

    My life turned upside down with the announcement of a bladder cancer diagnosis.

Leave a Comment

Cancel reply

Your email address will not be published. Required fields are marked *

NextPrevious

Recent Blog Posts

  • Announcing the Launch of Our New Hematuria Brochure: A Vital Resource for Early Bladder Cancer Detection 
  • Our First Annual Research Report Is Live! 
  • Economic Impacts of a Cancer Diagnosis on Canadians
  • Tax Season is Upon Us! 
  • Happy National Volunteer Week 2025!

Upcoming Events

  • Outreach Events
  • In-person Education Events
  • Support Groups
  • Webinars

Blog Categories

  • Blog
  • Honouring our volunteers
  • Latest news and stories
  • Patient Stories
  • Upcoming meeting and events
  • Volunteers
  • Webinar

Bladder Cancer Canada

4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org

Privacy Policy | Donor Bill of Rights

Charitable Reg No. 83612 6060 RR0001

© Bladder Cancer Canada.

SUBSCRIBE TO OUR NEWSLETTER
SEND US A MESSAGE
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
Bladder Cancer Canada